Kanada\u2019n\u0131n Britanya Kolumbiyas\u0131 (British Columbia) eyaletinde opioid ba\u011f\u0131ml\u0131l\u0131\u011f\u0131 ve a\u015f\u0131r\u0131 doz \u00f6l\u00fcmlerine kar\u015f\u0131 m\u00fccadele kapsam\u0131nda 2016 y\u0131l\u0131nda hekimlerin opioid re\u00e7ete etme davran\u0131\u015flar\u0131n\u0131 d\u00fczenleyen ba\u011flay\u0131c\u0131 bir uygulama standard\u0131 ba\u015flat\u0131ld\u0131. “K\u00f6t\u00fcye Kullan\u0131m\/Diversiyon Potansiyeli Olan \u0130la\u00e7lar\u0131n G\u00fcvenli Re\u00e7etelenmesi” olarak adland\u0131r\u0131lan bu standart, kronik kanser d\u0131\u015f\u0131 a\u011fr\u0131 (KDA) tedavisinde opioid kullan\u0131m\u0131n\u0131 s\u0131k\u0131 kurallara ba\u011flad\u0131. Ama\u00e7, opioidlerin a\u015f\u0131r\u0131 re\u00e7ete edilmesinden kaynaklanan krizle m\u00fccadele ederek halk sa\u011fl\u0131\u011f\u0131n\u0131 korumakt\u0131. Bu standart, hekimleri opioid re\u00e7etelerinin miktar\u0131n\u0131, s\u00fcresini ve kombinasyonlar\u0131n\u0131 dikkatli \u015fekilde y\u00f6netmeye zorlayarak re\u00e7etelenme al\u0131\u015fkanl\u0131klar\u0131nda \u00f6nemli bir de\u011fi\u015fime neden oldu.<\/p>\n
Birka\u00e7 y\u0131ld\u0131r s\u00fcren ara\u015ft\u0131rmalar, 2016\u2019daki uygulama standard\u0131n\u0131n opioid re\u00e7ete davran\u0131\u015flar\u0131n\u0131 derinden etkiledi\u011fini ortaya koyuyor. Britanya Kolumbiyas\u0131\u2019nda 2012\u2019den 2020\u2019ye kadar olan t\u00fcm opioid re\u00e7eteleri analiz edilerek, uygulama \u00f6ncesi ve sonras\u0131 trendler kar\u015f\u0131la\u015ft\u0131r\u0131ld\u0131. Ara\u015ft\u0131rmada kesintili zaman serisi analizi y\u00f6ntemi kullan\u0131ld\u0131. Sonu\u00e7 olarak, opioidlerin morfin miligram e\u015fde\u011feri (MME) cinsinden dozlar\u0131nda, \u00f6nceden devam eden azalma daha da h\u0131zland\u0131. Y\u00fcksek dozlu opioid re\u00e7eteleri ve opioidlere benzodiazepin gibi uyku verici ila\u00e7lar\u0131n e\u015f zamanl\u0131 verilme oranlar\u0131nda g\u00f6zle g\u00f6r\u00fcl\u00fcr d\u00fc\u015f\u00fc\u015fler saptand\u0131.<\/p>\n
Ara\u015ft\u0131rman\u0131n dikkat \u00e7ekici bulgular\u0131ndan biri, re\u00e7etelerde verilen toplam ila\u00e7 miktar\u0131n\u0131n azalmas\u0131yd\u0131. Bu, hekimlerin hastalara uzun s\u00fcreli ila\u00e7 teminini k\u0131s\u0131tlayarak, opioidlerin k\u00f6t\u00fcye kullan\u0131m ve ba\u011f\u0131ml\u0131l\u0131k riskini azaltmaya \u00e7al\u0131\u015ft\u0131\u011f\u0131n\u0131 g\u00f6steriyor. Ancak bu h\u0131zl\u0131 ve s\u0131k\u0131 denetim beraberinde istenmeyen bir etkiyi de getirdi: bir\u00e7ok hasta h\u0131zl\u0131 doz azaltma (tapering) s\u00fcrecine maruz kald\u0131. Klinik destek olmadan h\u0131zla azalt\u0131lan opioid dozlar\u0131, hastalar\u0131n a\u011fr\u0131 kontrol\u00fcnde yetersizlik ya\u015famalar\u0131na yol a\u00e7abilir. Bu durum, etkin a\u011fr\u0131 y\u00f6netiminin etik sorumlulu\u011fu ile opioid ba\u011f\u0131ml\u0131l\u0131\u011f\u0131 \u00f6nlemenin zorlu\u011funun nas\u0131l \u00e7eli\u015fti\u011fini somutla\u015ft\u0131r\u0131yor.<\/p>\n
McGill \u00dcniversitesi\u2019nden Dr. Dimitra Panagiotoglou liderli\u011findeki ara\u015ft\u0131rmac\u0131lar, bu durumu \u201crehberlerin \u00e7ift tarafl\u0131 etkisi\u201d olarak nitelendiriyor. Standartlar\u0131n kat\u0131 ve yanl\u0131\u015f yorumlanmas\u0131n\u0131n baz\u0131 hastalar i\u00e7in zarar verici olabilece\u011fine dikkat \u00e7ekiyorlar. Bu nedenle, uygulama standartlar\u0131n\u0131n geli\u015ftirilmesi ve yayg\u0131nla\u015ft\u0131r\u0131lmas\u0131 s\u0131ras\u0131nda hem hastalar\u0131n hem de sa\u011fl\u0131k \u00e7al\u0131\u015fanlar\u0131n\u0131n aktif dahil edilmesi gerekti\u011fini vurguluyorlar. S\u00fcrece kat\u0131l\u0131m, kamu sa\u011fl\u0131\u011f\u0131 beklentileri ile bireysel hasta gereksinimlerini dengeleyen daha esnek ve \u00f6zenli politikalar\u0131n ortaya \u00e7\u0131kmas\u0131n\u0131 sa\u011flayabilir.<\/p>\n
2016 standard\u0131n\u0131n yerini alan 2018\u2019deki revize rehber sayesinde opioid re\u00e7etelerindeki azalma h\u0131z\u0131 yava\u015flad\u0131. Bu geli\u015fme, hekimlerin davran\u0131\u015flar\u0131n\u0131n do\u011frudan d\u00fczenleyici metinlerin i\u00e7eri\u011fi ve kat\u0131l\u0131\u011f\u0131 ile ba\u011flant\u0131l\u0131 oldu\u011funu ortaya koyuyor. Dolay\u0131s\u0131yla, politika de\u011fi\u015fikliklerinin klinik uygulamalar \u00fczerinde h\u0131zl\u0131 ve etkili d\u00f6n\u00fc\u015f\u00fcm yaratabilece\u011fi anla\u015f\u0131l\u0131yor. Ancak, doz azaltma s\u00fcre\u00e7lerinin a\u015f\u0131r\u0131 s\u0131k\u0131 uygulanmas\u0131 hastalar\u0131 yasa d\u0131\u015f\u0131 ve riskli opioid kaynaklar\u0131na y\u00f6nlendirebiliyor. Bu da a\u015f\u0131r\u0131 doz ve bula\u015f\u0131c\u0131 hastal\u0131klar gibi sa\u011fl\u0131k sorunlar\u0131n\u0131n artmas\u0131yla sonu\u00e7lanabiliyor.<\/p>\n
Ayn\u0131 d\u00f6nemde yay\u0131mlanan yorum makalesi, kronik a\u011fr\u0131 ile opioid kullan\u0131m bozuklu\u011funu e\u015f zamanl\u0131 ya\u015fayan hastalar\u0131n tedavisinde kar\u015f\u0131la\u015f\u0131lan sistemik engelleri ortaya koydu. Kanadal\u0131 bir\u00e7ok hasta, kan\u0131ta dayal\u0131 tedavi y\u00f6ntemlerine eri\u015fimde s\u0131k\u0131nt\u0131 ya\u015f\u0131yor. Tedavi modellerinin birbirinden kopuk olmas\u0131, a\u011fr\u0131 y\u00f6netimi ile ba\u011f\u0131ml\u0131l\u0131k tedavisinin b\u00fct\u00fcnle\u015fik \u015fekilde yap\u0131lmas\u0131n\u0131 engelliyor. Bu durum, kapsaml\u0131 ve hasta merkezli bir yakla\u015f\u0131m\u0131n benimsenmesini zorla\u015ft\u0131r\u0131yor ve tedavi ba\u015far\u0131s\u0131n\u0131 d\u00fc\u015f\u00fcr\u00fcyor.<\/p>\n
Uzmanlar, \u00e7\u00f6z\u00fcm olarak disiplinleraras\u0131 ekiplerin kurulmas\u0131n\u0131 \u00f6neriyor. A\u011fr\u0131 y\u00f6netimi uzmanlar\u0131, ba\u011f\u0131ml\u0131l\u0131k tedavisi ekiplerine dahil edildi\u011finde, her iki hastal\u0131k da e\u015f zamanl\u0131 kontrol alt\u0131na al\u0131nabilir. B\u00f6ylece, hastalar\u0131n ya\u015fam kalitesi artarken, d\u0131\u015f kaynaklara y\u00f6nelimi ve olas\u0131 k\u00f6t\u00fcye kullan\u0131m riski azalabilir. Entegre tedavi modelleri, klinik uygulamada \u00f6nemli geli\u015fmeler vaat ediyor.<\/p>\n
\u00c7al\u0131\u015fma, opioid re\u00e7eteleme standartlar\u0131n\u0131n kamu sa\u011fl\u0131\u011f\u0131 politikalar\u0131 ve klinik karar alma s\u00fcre\u00e7leri \u00fczerinde ne denli g\u00fc\u00e7l\u00fc etkisi oldu\u011funu g\u00f6sterdi. Kesintili zaman serisi analizi metodolojisi sayesinde, standartlar\u0131n uygulanmas\u0131n\u0131n opioid dozlar\u0131n\u0131n azalmas\u0131nda neden-sonu\u00e7 ili\u015fkisi oldu\u011fu g\u00fcvenilir bi\u00e7imde ortaya kondu. Ancak, politikalar\u0131n ayn\u0131 zamanda esnek ve hasta odakl\u0131 olmas\u0131 gerekti\u011fi vurgulan\u0131yor.<\/p>\n
\u0130leriye d\u00f6n\u00fck olarak, politika yap\u0131c\u0131lar\u0131n Britanya Kolumbiyas\u0131 deneyiminden \u00e7\u0131kar\u0131lacak derslere kulak vermesi \u00f6nem ta\u015f\u0131yor. Klinik karar verme \u00f6zg\u00fcrl\u00fc\u011f\u00fcn\u00fc k\u0131s\u0131tlamayan, ancak net rehberlik sa\u011flayan esnek standartlar tasarlanmal\u0131. Bu ba\u011flamda hekimlerin, hastalar\u0131n, ba\u011f\u0131ml\u0131l\u0131k uzmanlar\u0131n\u0131n ve politika geli\u015ftiricilerin bir arada \u00e7al\u0131\u015fmas\u0131 hayati \u00f6nem ta\u015f\u0131yor. B\u00f6ylece opioid re\u00e7etelerinde hem kamu sa\u011fl\u0131\u011f\u0131 hedefleri hem de bireysel ihtiya\u00e7lar dengelenebilir.<\/p>\n
A\u011fr\u0131 y\u00f6netimi ve ba\u011f\u0131ml\u0131l\u0131k tedavisine entegre eri\u015fim art\u0131r\u0131lmal\u0131; b\u00f6ylece h\u0131zl\u0131 doz azaltmaya ba\u011fl\u0131 sorunlar azalacak ve tedavi s\u00fcreklili\u011fi sa\u011flanacak. \u0130la\u00e7 temelli olmayan a\u011fr\u0131 y\u00f6netimi y\u00f6ntemleri ve multimodal tedavi se\u00e7enekleri opioid ba\u011f\u0131ml\u0131l\u0131\u011f\u0131na kar\u015f\u0131 \u00f6nemli alternatifler sunuyor. Bu alanlarda yap\u0131lan yat\u0131r\u0131mlar, ba\u011f\u0131ml\u0131l\u0131\u011f\u0131 \u00f6nleme \u00e7abalar\u0131n\u0131 g\u00fc\u00e7lendirebilir.<\/p>\n
Opioid re\u00e7etelemenin fonksiyonel karma\u015f\u0131kl\u0131\u011f\u0131, analjezik etkinli\u011fi ile k\u00f6t\u00fcye kullan\u0131m risklerinin dengelenmesini gerektiriyor. \u00d6zellikle opioid ile merkezi sinir sistemi depresan\u0131 olan benzodiazepinlerin birlikte kullan\u0131m\u0131, solunum depresyonu gibi ciddi riskleri art\u0131r\u0131yor. Klinik uygulamada hastalar\u0131n bireysel de\u011ferlendirilmesi, d\u00fczenli takip ve tedavi planlar\u0131n\u0131n esnek \u015fekilde uyarlanmas\u0131 gerekiyor.<\/p>\n
Sonu\u00e7 olarak, Britanya Kolumbiyas\u0131\u2019ndaki ba\u015fl\u0131ca politika m\u00fcdahalesi opioid re\u00e7etelemede \u00f6nemli d\u00fc\u015f\u00fc\u015fler sa\u011flam\u0131\u015f olsa da, doz azaltma s\u00fcre\u00e7lerindeki sorunlar ve tedaviye eri\u015fim engelleri gibi zorluklar devam ediyor. Sa\u011fl\u0131k politikalar\u0131n\u0131n s\u00fcrekli de\u011ferlendirilmesi, \u00e7ok disiplinli bak\u0131m yakla\u015f\u0131mlar\u0131 ile desteklenmesi gerekiyor. B\u00f6ylelikle hem halk sa\u011fl\u0131\u011f\u0131 hem hasta refah\u0131 dengesi korunabilir ve opioid krizine kar\u015f\u0131 kapsaml\u0131 m\u00fccadele s\u00fcrd\u00fcr\u00fclebilir.<\/p>\n
Ara\u015ft\u0131rma, opioid re\u00e7etelerinde kontroller sa\u011fland\u0131\u011f\u0131nda klinik davran\u0131\u015flar\u0131n nas\u0131l de\u011fi\u015fti\u011fini ve opioid krizine y\u00f6nelik politika etkilerini anlamak i\u00e7in \u00f6nemli veriler sunuyor. Britanya Kolumbiyas\u0131 \u00f6rne\u011fi, di\u011fer b\u00f6lgeler i\u00e7in referans olu\u015fturacak nitelikte kapsaml\u0131 bir deneyim olarak kabul edilebilir. Kamu sa\u011fl\u0131\u011f\u0131 ve bireysel hasta gereksinimlerinin uyumlu hale getirilebilmesi i\u00e7in multidisipliner i\u015f birli\u011fi ka\u00e7\u0131n\u0131lmazd\u0131r.<\/p>\n
\u00d6n\u00fcm\u00fczdeki d\u00f6nemde opioid y\u00f6netimi konusunda yay\u0131mlanacak yeni politikalar\u0131n, mevcut deneyimlerden \u00f6\u011frenerek daha dengeli ve esnek olmas\u0131na ihtiya\u00e7 var. Hastalar\u0131n sesi politika yap\u0131m s\u00fcre\u00e7lerinde daha \u00e7ok duyulmal\u0131, klinisyenlerin karar verme alan\u0131 geni\u015fletilmeli ve etkili tedavi se\u00e7enekleri art\u0131r\u0131lmal\u0131. \u0130yi yap\u0131land\u0131r\u0131lm\u0131\u015f, bilimsel veriye dayal\u0131 ve hasta odakl\u0131 standartlar, opioid krizinin kontrol\u00fcnde en etkili ara\u00e7lardan biri olmaya devam edecektir.<\/p>\n
—<\/p>\n
**Ara\u015ft\u0131rma Konusu**: \u0130nsanlar
\n**Makale Ba\u015fl\u0131\u011f\u0131**: The effects of a provincial opioid prescribing standard on prescribing for pain in adults: an interrupted time-series analysis
\n**Haberin Yay\u0131n Tarihi**: 12-May-2025
\n**Web References**: http:\/\/dx.doi.org\/10.1503\/cmaj.250167
\n**Doi Referans**: 10.1503\/cmaj.250167
\n**Anahtar Kelimeler**: Madde ile ilgili bozukluklar, Opioid ba\u011f\u0131ml\u0131l\u0131\u011f\u0131, 2016 Safe Prescribing politikas\u0131 etkileri, Britanya Kolumbiyas\u0131 sa\u011fl\u0131k d\u00f6n\u00fc\u015f\u00fcm\u00fc, kronik kanser d\u0131\u015f\u0131 a\u011fr\u0131 y\u00f6netimi, benzodiazepinlerle e\u015f re\u00e7etelenme riskleri, opioid trendleri \u00fczerine ampirik ara\u015ft\u0131rmalar, y\u00fcksek doz opioid kullan\u0131m\u0131n\u0131n azalt\u0131lmas\u0131, re\u00e7ete d\u00fczenlemelerinin etkisi, opioid k\u00f6t\u00fcye kullan\u0131m\u0131 \u00f6nleme stratejileri, opioid a\u015f\u0131r\u0131 doz krizine yan\u0131t, Britanya Kolumbiyas\u0131\u2019nda opioid re\u00e7ete standartlar\u0131, opioid y\u00f6netimi uygulamalar\u0131, hekim davran\u0131\u015flar\u0131nda de\u011fi\u015fim.<\/p>\n","protected":false},"excerpt":{"rendered":"
Kanada\u2019n\u0131n Britanya Kolumbiyas\u0131 (British Columbia) eyaletinde opioid ba\u011f\u0131ml\u0131l\u0131\u011f\u0131 ve a\u015f\u0131r\u0131 doz \u00f6l\u00fcmlerine kar\u015f\u0131 m\u00fccadele kapsam\u0131nda 2016 y\u0131l\u0131nda hekimlerin opioid re\u00e7ete etme davran\u0131\u015flar\u0131n\u0131 d\u00fczenleyen ba\u011flay\u0131c\u0131 bir uygulama standard\u0131 ba\u015flat\u0131ld\u0131. “K\u00f6t\u00fcye Kullan\u0131m\/Diversiyon Potansiyeli Olan \u0130la\u00e7lar\u0131n G\u00fcvenli Re\u00e7etelenmesi” olarak adland\u0131r\u0131lan bu standart, kronik kanser d\u0131\u015f\u0131 a\u011fr\u0131 (KDA) tedavisinde opioid kullan\u0131m\u0131n\u0131 s\u0131k\u0131 kurallara ba\u011flad\u0131. Ama\u00e7, opioidlerin a\u015f\u0131r\u0131 re\u00e7ete edilmesinden…<\/p>\n","protected":false},"author":1,"featured_media":5520,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_yoast_wpseo_title":"","_yoast_wpseo_metadesc":"","_yoast_wpseo_focuskw":"","rank_math_title":"","rank_math_description":"","rank_math_focus_keyword":"","_wpan_schema_json_ld":"","_wpan_ai_seo_metadata":"","_wpan_ai_seo_status":"","_wpan_ai_seo_policy":"","_wpan_ai_seo_faq_block":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[28],"tags":[7156,7153,7154,7155,7152],"tmauthors":[],"class_list":{"0":"post-5519","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-kanser","8":"tag-hekimlerin-opioid-recete-yonetimi","9":"tag-kronik-kanser-disi-agrida-opioid-kullanimi","10":"tag-opioid-bagimliligi-onleme-politikalari-kanada","11":"tag-opioid-doz-azaltma-etkileri","12":"tag-opioid-recete-standartlari-britanya-kolumbiyasi"},"jetpack_featured_media_url":"https:\/\/haber360.com\/wp-content\/uploads\/2025\/05\/Revised-Opioid-Prescribing-Standards-Transformed-BC-Practices\u2014But-Challenges-Remain-basligi-icin-oneri-8220Opioid-Recete-Standartlari-BC8217de-Devrim-Yaratti-1747024193.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/5519","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/comments?post=5519"}],"version-history":[{"count":0,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/5519\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media\/5520"}],"wp:attachment":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media?parent=5519"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/categories?post=5519"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tags?post=5519"},{"taxonomy":"tmauthors","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tmauthors?post=5519"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}